世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000038567

薬剤溶出性バルーン市場調査レポートー2032年までの市場予測

Market Research Future

Drug Eluting Balloons Market Research Report - Market Forecast till 2032

発刊日 2024/06

言語英語

体裁PDF/128ページ

ライセンス/価格128ページ

0000038567

Single
Multiuser
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

薬剤溶出性バルーン市場調査レポート:製品別情報 (冠状動脈系薬剤溶出バルーン、末梢薬剤溶出バルーンなど)、技術別 (Paccocath、FreePac、TransPax、EnduraCoatなど)、エンドユーザー別 (病院・外来手術センター、カテーテル検査室など)、地域別 (北米、欧州、アジア太平洋、その他の地域)、2032年までの市場予測

薬剤溶出性バルーン市場の概要

薬剤溶出性バルーンの市場規模は、2023年に6億1,000万ドルと評価されました。この市場は、2024年の6億6,000万ドルから2032年までに11億ドルに成長し、予測期間 (2024年から2032年) の間に7.50 %のCAGRを示す見込みです。カテーテル検査室の需要の増加と有利な償還政策が、市場の成長を促進する主要因です。

レポート詳細

目次

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET INTRODUCTION
2.1. Definition
2.2. Scope of the Study
2.2.1. Research Objective
2.2.2. Assumptions
2.2.3.Limitations

3. RESEARCH METHODOLOGY
3.1. Overview
3.2. Data Mining
3.3. Secondary Research
3.4. Primary Research
3.4.1. Primary Interviews and Information Gathering Process
3.4.2.Breakdown of Primary Respondents
3.5. Forecasting Model
3.6. Market Size Estimation
3.6.1. Bottom-Up Approach
3.6.2. Top-Down Approach
3.7. Data Triangulation
3.8. Validation

4. MARKET DYNAMICS
4.1. Overview
4.2. Drivers
4.3. Restraints
4.4. Opportunities

5. MARKET FACTOR ANALYSIS
5.1. Value Chain Analysis
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining Power of Suppliers
5.2.2. Bargaining Power of Buyers
5.2.3. Threat of New Entrants
5.2.4. Threat of Substitutes
5.2.5. Intensity of Rivalry
5.3. COVID-19 Impact Analysis
5.3.1. Market Impact Analysis
5.3.2. Regional Impact
5.3.3. Opportunity and Threat Analysis

6. GLOBAL DRUG ELUTING BALLOONS MARKET, BY PRODUCT
6.1. Overview
6.2. Coronary Drug Eluting Balloon
6.3. Peripheral Drug Eluting Balloon
6.4. Others

7. GLOBAL DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY
7.1. Overview
7.2. Paccocath
7.3. FreePac
7.4. TransPax
7.5. EnduraCoat
7.6. Others

8. GLOBAL DRUG ELUTING BALLOONS MARKET, BY END-USER
8.1. Overview
8.2. Hospitals and Ambulatory Surgery Centers
8.3. Cath Labs
8.4. Others

9. GLOBAL DRUG ELUTING BALLOONS MARKET, BY REGION
9.1. Overview
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. Germany
9.2.2. France
9.2.3. UK
9.2.4. Italy
9.2.5. Spain
9.2.6. Rest of Europe
9.3. Asia-Pacific
9.3.1. China
9.3.2. India
9.3.3. Japan
9.3.4. South Korea
9.3.5. Australia
9.3.6. Rest of Asia-Pacific
9.4. Rest of the World
9.4.1. Middle East
9.4.2. Africa
9.4.3. Latin America

10. COMPETITIVE LANDSCAPE
10.1. Overview
10.2. Competitive Analysis
10.3. Market Share Analysis
10.4. Major Growth Strategy in the Global Drug Eluting Balloons Market,
10.5. Competitive Benchmarking
10.6. Leading Players in Terms of Number of Developments in the Global Drug Eluting Balloons Market,
10.7. Key developments and Growth Strategies
10.7.1. New Product Launch/Service Deployment
10.7.2. Merger & Acquisitions
10.7.3. Joint Ventures
10.8. Major Players Financial Matrix
10.8.1. Sales & Operating Income, 2023
10.8.2. Major Players R&D Expenditure. 2023

11. COMPANY PROFILES
11.1. Bayer AG
11.1.1. Company Overview
11.1.2. Financial Overview
11.1.3. Products Offered
11.1.4. Key Developments
11.1.5. SWOT Analysis
11.1.6. Key Strategies
11.2. Medtronic
11.2.1. Company Overview
11.2.2. Financial Overview
11.2.3. Products Offered
11.2.4. Key Developments
11.2.5. SWOT Analysis
11.2.6. Key Strategies
11.3. B. Braun Melsungen AG
11.3.1. Company Overview
11.3.2. Financial Overview
11.3.3. Products Offered
11.3.4. Key Developments
11.3.5. SWOT Analysis
11.3.6. Key Strategies
11.4. Cook Medical, Inc.
11.4.1. Company Overview
11.4.2. Financial Overview
11.4.3. Products Offered
11.4.4. Key Developments
11.4.5. SWOT Analysis
11.4.6. Key Strategies
11.5. BOSTON SCIENTIFIC CORPORATION
11.5.1. Company Overview
11.5.2. Financial Overview
11.5.3. Products Offered
11.5.4. Key Developments
11.5.5. SWOT Analysis
11.5.6. Key Strategies
11.6. Becton, Dickson and Company
11.6.1. Company Overview
11.6.2. Financial Overview
11.6.3. Products Offered
11.6.4. Key Developments
11.6.5. SWOT Analysis
11.6.6. Key Strategies
11.7. EuroCor
11.7.1. Company Overview
11.7.2. Financial Overview
11.7.3. Products Offered
11.7.4. Key Developments
11.7.5. SWOT Analysis
11.7.6. Key Strategies
11.8. TERUMO CORPORATION
11.8.1. Company Overview
11.8.2. Financial Overview
11.8.3. Products Offered
11.8.4. Key Developments
11.8.5. SWOT Analysis
11.8.6. Key Strategies
11.9. Koninklijke Philips N.V.
11.9.1. Company Overview
11.9.2. Financial Overview
11.9.3. Products Offered
11.9.4. Key Developments
11.9.5. SWOT Analysis
11.9.6. Key Strategies

12. APPENDIX
12.1. References
12.2. Related Reports

LIST OF TABLES
TABLE 1 GLOBAL DRUG ELUTING BALLOONS MARKET, SYNOPSIS, 2019-2032
TABLE 2 GLOBAL DRUG ELUTING BALLOONS MARKET, ESTIMATES & FORECAST, 2019-2032 (USD BILLION)
TABLE 3 GLOBAL DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 4 GLOBAL DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 5 GLOBAL DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 6 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 7 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 8 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 9 US: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 10 US: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 11 US: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 12 CANADA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 13 CANADA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 14 CANADA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 1 EUROPE: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 2 EUROPE: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 3 EUROPE: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 4 GERMANY: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 5 GERMANY: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 6 GERMANY: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 7 FRANCE: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 8 FRANCE: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 9 FRANCE: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 10 ITALY: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 11 ITALY: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 12 ITALY: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 13 SPAIN: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 14 SPAIN: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 15 SPAIN: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 16 UK: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 17 UK: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 18 UK: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 19 REST OF EUROPE: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 20 REST OF EUROPE: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 21 REST OF EUROPE: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 22 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 23 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 24 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 25 JAPAN: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 26 JAPAN: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 27 JAPAN: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 28 CHINA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 29 CHINA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 30 CHINA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 31 INDIA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 32 INDIA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 33 INDIA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 34 AUSTRALIA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 35 AUSTRALIA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 36 AUSTRALIA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 37 SOUTH KOREA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 38 SOUTH KOREA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 39 SOUTH KOREA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 40 REST OF ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 41 REST OF ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 42 REST OF ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 43 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 44 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 45 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 46 MIDDLE EAST: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 47 MIDDLE EAST: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 48 MIDDLE EAST: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 49 AFRICA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 50 AFRICA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 51 AFRICA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)
TABLE 52 LATIN AMERICA: DRUG ELUTING BALLOONS MARKET, BY PRODUCT, 2019-2032 (USD BILLION)
TABLE 53 LATIN AMERICA: DRUG ELUTING BALLOONS MARKET, BY TECHNOLOGY, 2019-2032 (USD BILLION)
TABLE 54 LATIN AMERICA: DRUG ELUTING BALLOONS MARKET, BY END-USER, 2019-2032 (USD BILLION)

LIST OF FIGURES
FIGURE 1 RESEARCH PROCESS
FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL DRUG ELUTING BALLOONS MARKET
FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL DRUG ELUTING BALLOONS MARKET
FIGURE 4 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY PRODUCT, 2023
FIGURE 5 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY TECHNOLOGY, 2023
FIGURE 6 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY END-USER, 2023
FIGURE 7 GLOBAL DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 8 NORTH AMERICA: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 9 EUROPE: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 10 ASIA-PACIFIC: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 11 REST OF THE WORLD: DRUG ELUTING BALLOONS MARKET, SHARE (%), BY REGION, 2023
FIGURE 12 GLOBAL DRUG ELUTING BALLOONS MARKET: COMPANY SHARE ANALYSIS, 2023 (%)
FIGURE 13 BAYER AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 14 BAYER AG: SWOT ANALYSIS
FIGURE 15 MEDTRONIC: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 16 MEDTRONIC: SWOT ANALYSIS
FIGURE 17 B. BRAUN MELSUNGEN AG: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 18 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS
FIGURE 19 COOK MEDICAL, INC.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 20 COOK MEDICAL, INC.: SWOT ANALYSIS
FIGURE 21 BOSTON SCIENTIFIC CORPORATION.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 22 BOSTON SCIENTIFIC CORPORATION.: SWOT ANALYSIS
FIGURE 23 BECTON, DICKSON AND COMPANY: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 24 BECTON, DICKSON AND COMPANY: SWOT ANALYSIS
FIGURE 25 EUROCOR: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 26 EUROCOR: SWOT ANALYSIS
FIGURE 27 TERUMO CORPORATION: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 28 TERUMO CORPORATION: SWOT ANALYSIS
FIGURE 29 KONINKLIJKE PHILIPS N.V.: FINANCIAL OVERVIEW SNAPSHOT
FIGURE 30 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS

この商品のレポートナンバー

0000038567

TOP